HealthStream, Inc.
HealthcareNASDAQ:HSTM · NASDAQ Global Select
-$0.09 today
Vol 0.18M · Avg 0.25M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
5.2%
avg 4.3%
ROIC
4.0%
avg 3.0%
ROA
3.5%
avg 3.0%
Analysis
ROE is currently the strongest return metric at 5.2% versus its period average of 4.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Robert A. Frist Jr. | Co-Founder, Chairman of the Board & Chief Executive Officer | $563,510.00 | — | 59 | $2,500.00 | <0.01% |
Michael Collier | Executive VP & COO | $545,179.00 | — | 50 | $18,781.00 | 0.06% |
Trisha L. Coady | Executive Vice President of Workforce Development Solutions | $530,547.00 | — | 50 | $40,877.00 | 0.14% |
Kevin O'Hara | Executive Vice President of Workforce Platform and Applications | $529,215.00 | — | 56 | $20,982.00 | 0.07% |
Scott Alexander Roberts | CFO and Senior VP of Accounting & Finance | $465,919.00 | — | 49 | $38,164.00 | 0.13% |
Jeffrey D. Cunningham | Senior Vice President & Chief Technology Officer | $369,050.00 | — | 59 | $25,748.00 | 0.09% |
Arthur E. Newman | Senior Executive Advisor | $326,534.00 | — | 77 | — | — |
Michael Scott McQuigg | Senior Vice President of Digital & Network Development | — | — | 58 | $18,781.00 | 0.06% |
Jennifer LoPresto | Senior Vice President of Sales | — | — | 53 | $6,859.00 | 0.02% |
Sneha Oakley | Vice President, Compliance Officer & General Counsel | — | — | — | — | — |
Mollie Condra | Vice President of Investor Relations & Communications | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
6
$311,565.50
Net Sentiment
$311,565.50
Net selling
Most Active
REBROVICK LINDA
2 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 6 sells worth $311,565.50 over the last 12 months. That adds up to net selling of $311,565.50. REBROVICK LINDA was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +0.0% | N/A1 analysts |
| Revenue | N/A | N/A | +26.3% | +4.3% (13yr)1 analysts |
| Net Income | N/A | N/A | +4.1% | N/A1 analysts |
| EBIT | N/A | N/A | +0.2% | +3.3% (13yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +26.3% over three years. Forward estimates point to Revenue at +4.3% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Butterfly Network, Inc.
NYSE:BFLY
$1.45B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
$1.19B
CareDx, Inc
NASDAQ:CDNA
$1.19B
Nutex Health, Inc.
NASDAQ:NUTX
$859.80M
Theravance Biopharma, Inc.
NASDAQ:TBPH
$857.84M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Evolent Health, Inc.
NYSE:EVH
$539.91M
Myriad Genetics, Inc.
NASDAQ:MYGN
$408.96M
Who manages HSTM?
HealthStream, Inc. (HSTM) lists 11 active executives. The top listed executive is Robert A. Frist Jr., Co-Founder, Chairman of the Board & Chief Executive Officer.
Are HSTM insiders buying or selling?
Recent insider activity shows net buying of $1.63M.
Explore More
Continue the stock analysis
Jump to another research area for this company.